Biogen Inc. buy Morgan Stanley
Start price
05.09.23
/
50%
€248.40
Target price
05.09.24
€355.70
Performance (%)
-27.13%
End price
06.09.24
€181.00
Summary
This prediction ended on 06.09.24 with a price of €181.00. The prediction for Biogen Inc. disappointed with a performance of -27.13%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.573% | 0.573% | 23.912% |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $363.00 to $381.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten